DOI: 10.1128/JVI.77.11.6305-6313.2003
Article Information
PubMed
Published By
History
- Received October 21, 2002
- Accepted March 7, 2003
- Published online June 1, 2003.
Copyright & Usage
Copyright © 2003 American Society for Microbiology
Author Information
- Danilo R. Casimiro1*,
- Ling Chen1,
- Tong-Ming Fu1,
- Robert K. Evans2,
- Michael J. Caulfield3,
- Mary-Ellen Davies1,
- Aimin Tang1,
- Minchun Chen1,
- Lingyi Huang1,
- Virginia Harris1,
- Daniel C. Freed1,
- Keith A. Wilson1,
- Sheri Dubey1,
- De-Min Zhu2,
- Denise Nawrocki2,
- Henryk Mach2,
- Robert Troutman2,
- Lynne Isopi2,
- Donna Williams2,
- William Hurni3,
- Zheng Xu1,
- Jeffrey G. Smith3,
- Su Wang3,
- Xu Liu3,
- Liming Guan1,
- Romnie Long1,
- Wendy Trigona1,
- Gwendolyn J. Heidecker1,
- Helen C. Perry1,
- Natasha Persaud1,
- Timothy J. Toner1,
- Qin Su1,
- Xiaoping Liang1,
- Rima Youil1,
- Michael Chastain1,
- Andrew J. Bett1,
- David B. Volkin1,
- Emilio A. Emini1 and
- John W. Shiver1
- 1Departments of Viral Vaccine Research
- 2Vaccine Pharmaceutical Research and Development
- 3Virus and Cell Biology, Merck Research Laboratories, Merck and Company, West Point, Pennsylvania 19486
- ↵* Corresponding author. Mailing address: Department of Viral Vaccine Research, Merck & Co., WP26-145, 770 Sumneytown Pike, West Point, PA 19486. Phone: (215) 652-3129. Fax: (215) 652-7320. E-mail: danilo_casimiro{at}merck.com .
